Study S000857

Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes Insufficiently Controlled by Insulin Glargine and Metformin Combination Therapy

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04893148
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 40
Start: 2020-05-26
Primary completion: 2021-12-30
Lead sponsor: Chungbuk National University Hospital
Conditions: Type 2 Diabetes Mellitus; Glucose, High Blood
Interventions: DRUG:IGlarLixi; DRUG:Dulaglutide
Results posted: FALSE

Registered primary outcomes

Changes in glycated hemoglobin (HbA1c) [Baseline, week 12]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.